OH-PROCTER-&-GAMBLE
26.4.2019 15:02:04 CEST | Business Wire | Press release
In celebration of Earth Week and to further its commitment to drive a more sustainable future, the Procter & Gamble Company (NYSE:PG) announced a new collaboration with Malaysia Institute for Supply Chain Innovation (MISI), International Plant Nutrition Institute (IPNI) and Yara International to help improve the livelihood of smallholders within the P&G palm supply chain in Malaysia. After a successful pilot ran between 2015 and 2018, the Company is expanding the program that partners with independent palm oil smallholders to increase their overall fruit yields through the training and implementation of best-in-class, and more sustainable agricultural practices.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190426005048/en/
P&G is committed to the responsible sourcing of palm and has declared livelihood improvement for the palm oil smallholders as one of its Ambition 2030 environmental sustainability goals. Today, smallholders provide about 40% of the world’s palm oil supply, however many of them have limited knowledge or access to agricultural resources to help maximize their crop.
The pilot was focused on assessing the baseline capability of around 2000 smallholder farmers in the state of Johor, Malaysia. Given its success, the program is expanding to create 250 learning farms which will be embedded in a P&G-led innovation system. These farms will serve as community resource centers to drive scale and diffusion of good agricultural practices for up to 10,000 smallholders within the next five years. The goal is to improve yields by 30-50%, improve the livelihood of the smallholder farmers and ensure sustainable practices in the P&G palm oil supply chain.
“We believe we can be a force for good and a force for growth. This program illustrates our commitment to driving long-term sustainability efforts,” said Jack Ryan, Vice President, P&G Chemicals. “We are proud of the work we are doing in Malaysia because it is the right thing to do for the local community and the global consumers we serve who want more sustainable products.”
The farmers of the 250 learning farms will have direct access to agronomists and sustainability field officers and receive hands-on technical advisory support. Together, they will work to implement best-in-class farm operations management including harvesting optimization, nutrient plans and budget management. In return, these smallholders will act as resource trainers and scale the effort to other farmers in their community.
P&G believes this effort is helping move the smallholders in the right direction and is setting them up for long-term success. Sustainability of the system is underpinned by a common and shared vested interest of smallholders, oil palm processors and fertilizer supply chains. The goal is to increase productivity of farms and to meet the continued demand for sustainable palm oil and palm kernel oil.
About Procter & Gamble
P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G community includes operations in approximately 70 countries worldwide. Please visit http://www.pg.com for the latest news and information about P&G and its brands.
About MISI (Malaysia Institute for Supply Chain Innovation)
Located in Shah Alam, Malaysia near Kuala Lumpur, the Malaysia Institute for Supply Chain Innovation (MISI) is one of the six centers in the MIT Global SCALE (Supply Chain and Logistics Excellence) Network. The institute was launched as a joint initiative between the Massachusetts Institute of Technology (MIT) and the government of Malaysia. The MIT Global SCALE Network is an international alliance of leading edge research and educational organizations, dedicated to the development and dissemination of global innovation in supply chain and logistics.
About Yara
Yara grows knowledge to responsibly feed the world and protect the planet, to fulfill our vision of a collaborative society, a world without hunger and a planet respected. To meet these commitments, we have taken the lead in developing digital farming tools for precision farming and work closely with partners throughout the whole food value chain to develop more climate-friendly crop nutrition solutions. In addition, we are committed to working towards sustainable mineral fertilizer production. We foster an open culture of diversity and inclusion that promotes the safety and integrity of our employees, contractors, business partners, and society at large. Founded in 1905 to solve the emerging famine in Europe, Yara has a worldwide presence with about 17,000 employees and operations in over 60 countries. In 2018, Yara reported revenues of USD 12.9 billion. www.yara.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20190426005048/en/
Contact:
P&G Contact: Robyn Schroeder P&G Global Communications Email: Schroeder.rm@pg.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom